dactinomycin and er-086526

dactinomycin has been researched along with er-086526 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Iwata, S; Kawai, A; Kondo, T; Noguchi, R; Ono, T; Sin, Y; Sugaya, J; Tsuchiya, R; Yoshida, A; Yoshimatsu, Y	1

Other Studies

1 other study(ies) available for dactinomycin and er-086526

Article	Year
Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma. Human cell, 2021, Volume: 34, Issue:6 Topics: Aged; Antineoplastic Agents; Bortezomib; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Depsipeptides; DNA Copy Number Variations; Docetaxel; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Furans; Humans; Ketones; Neoplasm Invasiveness; Spheroids, Cellular	2021

Article

Year

Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.

Human cell, 2021, Volume: 34, Issue:6

Topics: Aged; Antineoplastic Agents; Bortezomib; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Depsipeptides; DNA Copy Number Variations; Docetaxel; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Furans; Humans; Ketones; Neoplasm Invasiveness; Spheroids, Cellular

2021